Pro2Health, Inc.

Pro2Health manufactures PrO2, a cloud-connected respiratory muscle training (RMT) system for healthcare, fitness, and research applications. The company's proprietary TIRE (Threshold Inspiratory Resistance Exercise) methodology delivers full-breath resistance training to strengthen the diaphragm and intercostal muscles. The platform comprises professional-grade handheld devices, native iOS/Android mobile applications, Windows-based clinician dashboards, and HIPAA-aligned cloud infrastructure for remote monitoring and data analytics. Devices are FDA registered and CE marked. The system supports multi-user operation via disposable filters, real-time biofeedback, and wireless charging on select models. Clinical applications include COPD, heart failure, asthma, Long-COVID, and 15+ additional respiratory and cardiovascular conditions validated across 40+ peer-reviewed studies spanning 25+ years of research. The platform offers CPT code support for reimbursement, clinician mode for patient customization and progress tracking, and IRB-compliant protocols for research deployments. Fitness applications target endurance, VO2 max optimization, and athletic performance enhancement. Subscription tiers provide unlimited data storage, analytics, and multi-site management for clinics and research institutions. Raw data export and API access available for research partners. The company serves healthcare professionals, athletes, trainers, patients, and researchers globally.